News Archive of Outsourcing-Pharma

ArticleAdded
Consolidation prevalent in industry, says third largest CMO03-26-14
Catalent commits to ADCs by upping its stake in Redwood03-25-14
Catalent commits to ADCs by upping its stake in Redwood03-25-14
Consolidation prevalent in industry, says third largest CMO03-26-14
Patheon and DSM crossover limited, more growth targeted says DPx03-20-14
Patheon and DSM crossover limited, more growth targeted says DPx03-20-14
Kemwell CEO says environmental efforts are worth the cost11-26-13
Catalent launches softgel products at CPhI: one vegetarian, one anti-abuse10-23-13
Kemwell Talks Expansion and Approvals in India and the US05-27-13
TFS Sees Increase in Modularization, Shorter Construction Timelines05-21-13
AlpVision's iPhone Tech Offers Authentication in War on Counterfeits05-07-13
AMRI Exec Discusses 'New Bar' in FDA Enforcement05-01-13
Happy holidays from William Reed Business Media!12-19-12
Aesica says academic partnerships are key for CMOs12-06-12
Is risk-based clinical trial monitoring too flexible for the regulators?11-12-12
Cobra Biologics talks recent fill finish acquisition and future growth plans10-25-12
Catalent says sharing with industry will not dull competetive edge10-22-12
Bend Research hunting new partnerships to boost bioavailability offering10-17-12
Changes to EU clinical trial laws will mean fairer playing field, says Clinipace08-21-12
Wockhardt targets CMO space for diversification06-14-12
Overhaul of EU health systems good opportunity for outcomes data providers, says Quintiles06-07-12
Home visits = regulatory thumbs up? ResearchNurses.co thinks so05-31-12
Home visits are the key to patient retention, says ResearchNurses.co05-30-12
Kemwell and Boehringer set to finish biologics plant in India05-29-12
R&D and commercial work together to design trials, says DIA05-22-12
Patheon launches CMC consultancy in face of restructuring plans05-15-12
Kemwell CEO says environmental efforts are worth the cost11-26-13
Catalent launches softgel products at CPhI: one vegetarian, one anti-abuse10-23-13
TFS Sees Increase in Modularization, Shorter Construction Timelines05-21-13
Is risk-based clinical trial monitoring too flexible for the regulators?11-12-12
Cobra Biologics talks recent fill finish acquisition and future growth plans10-25-12
Catalent says sharing with industry will not dull competetive edge10-22-12
Bend Research hunting new partnerships to boost bioavailability offering10-17-12
Kemwell Talks Expansion and Approvals in India and the US05-27-13
TFS Sees Increase in Modularization, Shorter Construction Timelines05-21-13
AlpVision's iPhone Tech Offers Authentication in War on Counterfeits05-07-13
AMRI Exec Discusses 'New Bar' in FDA Enforcement05-01-13
Happy holidays from William Reed Business Media!12-19-12
Aesica says academic partnerships are key for CMOs12-06-12
Changes to EU clinical trial laws will mean fairer playing field, says Clinipace08-21-12
Wockhardt targets CMO space for diversification06-14-12
Overhaul of EU health systems good opportunity for outcomes data providers, says Quintiles06-07-12
Home visits = regulatory thumbs up? ResearchNurses.co thinks so05-31-12
Home visits are the key to patient retention, says ResearchNurses.co05-30-12
Kemwell and Boehringer set to finish biologics plant in India05-29-12
R&D and commercial work together to design trials, says DIA05-22-12
Patheon launches CMC consultancy in face of restructuring plans05-15-12
SGS adds formulation development services and expands US lab05-07-12
Once a friend now an enemy: Over zealous EU regulators could hamper the CMO market, says analyst04-25-12
Pharmas must give patients voice says DIA Europe director04-19-12
Improve patient compliance by designing trials around real life, says expert04-16-12
People special: social media gets job hunters noticed04-10-12
Regulatory changes: the experts give us their thoughts at DIA Euromeeting04-05-12
Catalent eyes emerging market expansion of end-to-end development service model04-04-12
Comparator sourcing is a complex challenge in a globalised market says Clinigen03-27-12
Pharma needs to rethink supply chains in an era of patent expiry and global outsourcing03-26-12
European CMO market will double in just 6 years, says Frost & Sullivan03-15-12
Social network sites is key to trial recruitment success, says expert02-27-12
Social network sites key to trial recruitment success, says expert02-27-12
An experienced CMO is key to successful biologics development says Cobra Biologics01-25-12
Parexel discusses transdermal drug delivery techs12-22-11
Sponsors and CROs differ on perception of service quality, says the Avoca Group12-08-11
Recipharm CEO talks CMO sector recovery and Asian plans12-05-11
Covance adding mass spec for biosimilars11-23-11
Embedded service providers are future of the industry, says RPS11-21-11
Almac sees growing demand for non-GMP contracting11-15-11
Patheon mulls drug delivery tech deals to accelerate development services growth11-14-11
Patheon mulls drug delivery tech deals to accelerate development services expansion11-14-11
The right questions key to assessing CRO performance, says study team11-09-11
Catalent eyes acquisitions in emerging market and drug delivery expansion11-07-11
Piramal expands ADC capacity predicting market growth11-03-11
Piramal expands ADC capacity predict market growth11-03-11
Icon sets its sights on genomics development10-31-11
Aenova sees CMO demand coming back to Europe10-31-11
Norwich amps up its pilot scale production capabilities at NY plant10-27-11
CROs' complex demands are changing the tissue supply biz, says industry expert09-27-11
Novozymes reveals the key to its supply chain management strategy09-26-11
New growth strategy and supply chain management system in place for SAFC, says president Gilles Cottier09-19-11
Pharma sponsors want better quality CRO performance data, says CRO Analytics09-14-11
Patient Recruitment Outsourcing in emerging markets: the good, the bad, and the ugly08-31-11
Patient recruitment must evolve, says Cutting Edge Information08-18-11
Rapid recruitment in emerging regions can overload sites; FDA08-18-11
Patient recruitment best outsourced, says market analyst08-16-11
Apps turn iPads & iPods into consent & compliance tools08-08-11
Sponsors and CROs both have key role in quality; FDA08-03-11
ACRO, Quintiles, PRA and Theorem talk strategic partnering at DIA 201108-02-11
Realistic, evidence-based patient recruitment goals are key, Shire08-01-11
INC Research CEO reflects on Kendle acquisition07-28-11
INC Research CEO reflects on Kendle acqusition07-28-11
OSP meets Pfizer's REMOTE virtual trial partners at DIA 201107-27-11
Quintiles talks about challenges of data management in today's trials sector07-13-11
Fiscal benefits of drugs a priority for cash-strapped countries07-12-11
Strategic relationships are changing Pharma and CRO skillset says Parexel07-07-11
Synteract talks rescue studies at DIA 201107-06-11
Parexel talks global trial regulations at DIA 201107-04-11
Chiltern says strategic deals are good for the CRO sector06-30-11
Quintiles launches silo busting data management platform at DIA06-29-11
Celerion talks about research sector in South America06-28-11
PRA reflects on data and information management at DIA06-27-11
Medidata to add SaaS CTMS through Clinical Force buy06-23-11
Firecrest's site performance software goes mobile06-21-11
Parexel CEO reflects on Pfizer deal06-06-11
Almac talks expansion at Interphex 201104-20-11
EDT talks about the contract manufacturing market at Interphex04-14-11
Patheon talks about backup manufacturing service at Interphex 201104-06-11
Social media boosting patient recruitment, but FDA guidance needed03-14-11
Biopharm waste material mix a chance to cut landfill costs03-09-11
Contract packagers must adapt to surge in serialisation03-01-11
Big pharma more open to strong relationships, less heavy handed02-03-11
Interest in functional service model on the rise; Chiltern12-23-10
PKPD ?ingrained? in development and evolution will continue12-15-10
PPD Pennsylvania cGMP lab benefiting from vaccine centre12-08-10
?Guinea piggers? at large in the pharmaceutical industry11-30-10
SCM talks US demand for niche contracting at AAPS11-23-10
Industry, innovation & Viagra-stuffed teddies at AAPS11-22-10
New analytical services biz plans growth in tough market11-22-10
Icon inks Proteome deal to bolster biomarker offering11-18-10
Quotient and Bend discuss new collaboration at AAPS11-17-10
PRA unveils new US bioanalytical lab at AAPS11-16-10
Indian HPAPI capacity puts Arch in profitable, emerging niche11-09-10
IDT sees big potential in vaccine contracting10-18-10
Biopharm sees large future for media enhanced packaging10-14-10
Almac invests in biocatalysis lauding cost and environmental benefits10-13-10
Global reach key for CDMOs, says Recipharm CEO10-12-10
EDT talks about new OSD contracting biz10-11-10
BioClinica bites back at Nicusa Capital's call for leadership changes10-07-10
REMS a cross departmental challenge for drugmakers says PPD09-22-10
Biopharma needs value focused commercial model, says Quintiles09-16-10
eClinical talks future of data management09-15-10
Patient recruiters & regulators educating each other as trials globalise09-07-10
KCAS talks biomarker strategy development08-30-10
Almac Diagnostics discusses new biomarker service08-26-10
Asia Pacific trial sector poised for continued growth, says Novotech08-25-10
ERT develops IVR suicidality monitoring for trials08-02-10
Demand for discovery services recovering, says Domainex07-29-10
Biomarkers ?indispensible? in cancer drug development, says Quintiles07-27-10
Data, patients and payers key to ?New Health? success, says Quintiles07-13-10
Safety and value driving Phase IV growth at CROs; EVP06-03-10
Potential for trials in Russia "enormous", says ClinStar04-13-10
US presence is a must for biologics producers, says Recipharm03-29-10
Liquent and Take Solutions team on regulatory submissions03-24-10
INC forms ePRO partnership with invivodata03-16-10
Centralising ECG trial data can cut costs 40%, says ERT 03-15-10
Quintiles opens Nairobi office 03-11-10
Adaptive approach to trial design and operation is key, Health Decisions03-10-10
Electronic submission offers benefits for pharma, says ISI03-09-10
SAFC preparing for inevitable shift to cell culture vaccines02-25-10
Informex ? companies hope for a brighter 2010 02-22-10
MDS' sites "perfectly dovetail" with Ricerca's capacity; VP02-17-10
Trial sponsors and CROs must do more to recruit older people, says EU group 02-16-10
Intelligent packaging can cut cost of trials; Stora Enso02-11-10
MENA emerging as trial destination says ClinTec CEO02-08-10
Adaptive methods can improve personalised medicine trials; CEO01-14-10
Seasonal Video Greetings From Decision News Media 12-22-09
14 C "synth to clinic" simplifies development process, says Quotient CEO11-24-09
AAPS - trends in turbulent times11-12-09
AAPS - round up of day one11-10-09
OctoPlus, Glycotope, Merck KGaA and SCM Pharma on BioPh 200910-29-09
CPhI 2009 - Road to recovery?10-15-09
Gene therapy to drive viral and biologics market, says SAFC 10-14-09
CPhI 2009 show preview10-08-09
Transcrip offers experts to augment in-house drug development09-09-09
Symyx launches CDMO06-03-09
Meet Our New Owners06-03-09
Quotient Bioresearch buys Edinburgh facility and sets up new clinical unit05-20-09